跳至主要内容
临床试验/IRCT2013020712391N1
IRCT2013020712391N1已完成1 期

Investigating the Effect of Onopordon Acanthium Seed on Primary Hypertension Reduction in Patients under Treatment by Losartan

Tehran University of Medical Sciences0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Inclusion Criteria: Aged between 30 and 60; SBP>= 140; DBP >= 90 mmHg; Patient under treatment by Losartan (50 mg);

排除标准

  • Existence of malignant hypertension, i.e. blood pressure higher than 200/140 mmHg which needs multi-drug treatment or emergency IV drug infusion to control blood pressure; History of secondary hypertension ; Existence of end organ damages (EOD); Sudden increase of blood pressure to greater than 15 mmHg at any time during the study; Existence of any kind of cardiac arrhythmias; Symptomatic valvular heart diseases (except mitral valve prolapse); Liver function disorders; Pregnancy and lactation; Cured or uncured malignancy during the last 5 years; Serum potassium >5.2 or <3.5 mEq/L in the first visit; Drug or alcohol usage background; Any kind of disorder (medical or surgical) which can interfere the study

研究者

相似试验

Investigating the Effect of Onopordon Acanthium Seed... | 临床试验